COL10A1 is an important and specifically expressed collagen whose role in the progression of solid tumors is an area of active study; our results suggest that it holds substantial value as a regulator and biomarker of aggressive tumor phenotypes with implications for ECM-targeted therapies and clinical outcomes. This evidence concerns the gene COL10A1 and neoplasm.